Pictet-Spenglerase involved in tetrahydroisoquinoline antibiotic biosynthesis

Current Opinion in Chemical Biology

Volumn 16, Issue 1-2, 2012, Pages 142-149

  Koketsu, Kento ^a   Minami, Atsushi ^a   Watanabe, Kenji ^b   Oguri, Hiroki ^a   Oikawa, Hideaki ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

^b UNIVERSITY OF SHIZUOKA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; FUKUTIN; NATURAL PRODUCT; NONRIBOSOMAL PEPTIDE SYNTHETASE; PYOVERDINE; QUINOCARCIN; SAFRAMYCIN A; SAFRAMYCIN B; TETRAHYDROISOQUINOLINE; TRABECTEDIN;

ANTIBIOTIC BIOSYNTHESIS; CATALYSIS; NONHUMAN; PICTET SPENGLER REACTION; REVIEW; X RAY CRYSTALLOGRAPHY;

ANTI-BACTERIAL AGENTS; BIOCATALYSIS; PEPTIDE BIOSYNTHESIS, NUCLEIC ACID-INDEPENDENT; PEPTIDE HYDROLASES; TETRAHYDROISOQUINOLINES;

EID: 84859633428     PISSN: 13675931     EISSN: 18790402     Source Type: Journal    
DOI: 10.1016/j.cbpa.2012.02.021     Document Type: Review

References (38)

1. Finking R., Marahiel M.A. Biosynthesis of nonribosomal peptides. Annu Rev Microbiol 2004, 58:453-488.
2. Fischbach M.A., Walsh C.T. Assembly-line enzymology for polyketide and nonribosomal Peptide antibiotics: logic, machinery, and mechanisms. Chem Rev 2006, 106:3468-3496.
3. Watanabe K., Oguri H., Oikawa H. Diversification of echinomycin molecular structure by way of chemoenzymatic synthesis and heterologous expression of the engineered echinomycin biosynthetic pathway. Curr Opin Chem Biol 2009, 13:189-196.
4. Tanovic A., Samel S.A., Essen L.O., Marahiel M.A. Crystal structure of the termination module of a nonribosomal peptide synthetase. Science 2008, 321:659-663.
5. Scott J.D., Williams R.M. Chemistry and biology of the tetrahydroisoquinoline antitumor antibiotics. Chem Rev 2002, 102:1669-1730.
6. Arai T., Takahashi K., Kubo A. New antibiotics saframycins A, B, C, D and E. J Antibiot 1977, 30:1015-1018.
7. Sakai R., Rinehart K.L., Guan Y., Wang A.H.J. Additional antitumor ecteinascidins from a caribbean tunicate - crystal-structures and activities in vivo. Proc Natl Acad Sci USA 1992, 89:11456-11460.
8. Fayette J., Coquard I.R., Alberti L., Ranchere D., Boyle H., Blay J.Y. ET-743: a novel agent with activity in soft tissue sarcomas. Oncologist 2005, 10:827-832.
9. Cuevas C., Francesch A. Development of Yondelis (trabectedin, ET-743). A semisynthetic process solves the supply problem. Nat Prod Rep 2009, 26:322-337.
10. Koketsu K., Watanabe K., Suda H., Oguri H., Oikawa H. Reconstruction of the saframycin core scaffold defines dual Pictet-Spengler mechanisms. Nat Chem Biol 2010, 6:408-410.
11. Tomita F., Takahashi K., Tamaoki T. Quinocarcin, a novel antitumor antibiotic. 3. Mode of action. J Antibiot 1984, 37:1268-1272.
12. Fukuyama T., Sachleben R.A. Stereocontrolled total synthesis of (+/-)-saframycin-B. J Am Chem Soc 1982, 104:4957-4958.
13. Stoeckigt J., Antonchick A.P., Wu F., Waldmann H. The Pictet-Spengler reaction in nature and in organic chemistry. Angew Chem Int Ed 2011, 50:8538-8564.
14. Mikami Y., Takahashi K., Yazawa K., Arai T., Namikoshi M., Iwasaki S., Okuda S. Biosynthetic studies on saframycin A, a quinone antitumor antibiotic produced by Streptomyces lavendulae. J Biol Chem 1985, 260:344-348.
15. Li L., Deng W., Song J., Ding W., Zhao Q.F., Peng C., Song W.W., Tang G.L., Liu W. Characterization of the saframycin A gene cluster from Streptomyces lavendulae NRRL 11002 revealing a nonribosomal peptide synthetase system for assembling the unusual tetrapeptidyl skeleton in an iterative manner. J Bacteriol 2008, 190:251-263.
16. Velasco A., Acebo P., Gomez A., Schleissner C., Rodríguez P., Aparicio T., Conde S., Muñoz R., de la Calle F., Garcia J.L., et al. Molecular characterization of the safracin biosynthetic pathway from Pseudomonas fluorescens A2-2: designing new cytotoxic compounds. Mol Microbiol 2005, 56:144-154.
17. Pospiech A., Bietenhader J., Schupp T. Two multifunctional peptide synthetases and an O-methyltransferase are involved in the biosynthesis of the DNA-binding antibiotic and antitumour agent saframycin Mx1 from Myxococcus xanthus. Microbiology 1996, 142:741-746.
18. Christopher M.Rath, Benjamin Janto, Josh Earl, Azad Ahmed, Fen Z.Hu, Luisa Hiller, Meg Dahlgren, Rachael Kreft, Fengan Yu, Jeremy J.Wolff, et al. Meta-omic characterization of the marine invertebrate microbial consortium that produces the chemotherapeutic natural product ET-743. ACS Chem Biol 2011, 6:1244-1256.
19. Schmidt E.W., Nelsona J.T., Fillmorea J.P. Synthesis of tyrosine derivatives for saframycin MX1 biosynthetic studies. Tetrahedron Lett 2004, 45:3921-3924.
20. Jeedigunta S., Krenisky J.M., Kerr R.G. Diketopiperazines as advanced intermediates in the biosynthesis of ecteinascidins. Tetrahedron 2000, 56:3303-3307.
21. Baltz R.H., Miao V., Wrigley S.K. Natural products to drugs: daptomycin and related lipopeptide antibiotics. Nat Prod Rep 2005, 22:717-741.
22. Zhang Z.N., Zhou R., Sauder J.M., Tonge P.J., Burley S.K., Swaminathan S. Structural and functional studies of fatty acyl adenylate ligases from E. coil and L. pneumophila. J Mol Biol 2011, 406:313-324.
23. Rausch C., Hoof I., Weber T., Wohlleben W., Huson D.H. Phylogenetic analysis of condensation domains in NRPS sheds light on their functional evolution. BMC Evol Biol 2007, 7.
24. Du L., Sanchez C., Chen M., Edwards D.J., Shen B. The biosynthetic gene cluster for the antitumor drug bleomycin from Streptomyces verticillus ATCC15003 supporting functional interactions between nonribosomal peptide synthetases and a polyketide synthase. Chem Biol 2000, 7:623-642.
25. Visca P., Imperi F., Lamont I.L. Pyoverdine siderophores: from biogenesis to biosignificance. Trends Microbiol 2007, 15:22-30.
26. Gulick E.J., Da A.M. Structural characterization and high-throughput screening of inhibitors of PvdQ, an NTN hydrolase involved in pyoverdine synthesis. ACS Chem Biol 2011, 6:1277-1286.
27. Zaleta-Rivera K., Xu C.P., Yu F.G., Butchko R.A.E., Proctor R.H., Hidalgo-Lara M.E., Raza A., Dussault P.H., Du L.C. A bidomain nonribosomal peptide synthetase encoded by FUM14 catalyzes the formation of tricarballylic esters in the biosynthesis of fumonisins. Biochemistry 2006, 45:2561-2569.
28. Ding Y.S., Rath C.M., Bolduc K.L., Hakansson K., Sherman D.H. Chemoenzymatic synthesis of cryptophycin anticancer agents by an ester bond-forming non-ribosomal peptide synthetase module. J Am Chem Soc 2011, 133:14492-14495.
29. Lin S., Van Lanen S.G., Shen B. A free-standing condensation enzyme catalyzing ester bond formation in C-1027 biosynthesis. Proc Natl Acad Sci USA 2009, 106:4183-4188.
30. Marshall C.G., Hillson N.J., Walsh C.T. Catalytic mapping of the vibriobactin biosynthetic enzyme VibF. Biochemistry 2002, 41:244-250.
31. Samel S.A., Schoenafinger G., Knappe T.A., Marahiel M.A., Essen L.O. Structural and functional insights into a peptide bond-forming bidomain from a nonribosomal peptide synthetase. Structure 2007, 15:781-792.
32. Kopp F., Mahlert C., Grunewald J., Marahiel M.A. Peptide macrocyclization: the reductase of the nostocyclopeptide synthetase triggers the self-assembly of a macrocyclic imine. J Am Chem Soc 2006, 128:16478-16479.
33. Sims J.W., Schmidt E.W. Thioesterase-like role for fungal PKS-NRPS hybrid reductive domains. J Am Chem Soc 2008, 130:11149-11155.
34. Liu X.Y., Walsh C.T. Cyclopiazonic acid biosynthesis in Aspergillus sp.: characterization of a reductase-like R* domain in cyclopiazonate synthetase that forms and releases cyclo-acetoacetyl-l-tryptophan. Biochemistry 2009, 48:8746-8757.
35. Read J.A., Walsh C.T. The lyngbyatoxin biosynthetic assembly line: chain release by four-electron reduction of a dipeptidyl thioester to the corresponding alcohol. J Am Chem Soc 2007, 129:15762-15763.
36. Xue Y., Sherman D.H. Alternative modular polyketide synthase expression controls macrolactone structure. Nature 2000, 403:571-575.
37. Kittendorf J.D., Beck B.J., Buchholz T.J., Seufert W., Sherman D.H. Interrogating the molecular basis for multiple macrolactone ring formation by the pikromycin polyketide synthase. Chem Biol 2007, 14:944-954.
38. Bennett B.D., Kimball E.H., Gao M., Osterhout R., Van Dien S.J., Rabinowitz J.D. Absolute metabolite concentrations and implied enzyme active site occupancy in Escherichia coli. Nat Chem Biol 2009, 5:593-599.